Clinical News

Supplement Recalled, Contained Dangerous Additives
Supplement Recalled, Contained Dangerous AdditivesKiriko is recalling all lots of its weight-loss supplement.
Why a Pharmacy School Cancelled Marijuana Classes
Why a Pharmacy School Cancelled Marijuana ClassesMedical cannabis classes will no longer be held at the University of Maryland-Baltimore.
How Pharmacists Can Fight Antimicrobial ResistanceA pharmacy organization says all health-providers need to help prevent and fight antimicrobial resistance.
FDA Safety Communication for Ocaliva
FDA Safety Communication for OcalivaFDA issues new communication about risk of liver injury with Ocaliva (obeticholic acid).
FDA Okays Benzodiazepines and Medication-Assisted Opioid Addiction Treatment
FDA Okays Benzodiazepines and Medication-Assisted Opioid Addiction TreatmentA new communication says benzodiazepines can be used with buprenorphine or methadone, if carefully managed.
FDA Considers Compounding Pharmacy RegulationsGottlieb says that changes may be coming, but remains firm on current regulations.
FDA Sends Warning Letter to EpiPen Manufacturer
FDA Sends Warning Letter to EpiPen ManufacturerEpiPen manufacturer is accused of lax investigation into problems.
FDA Warning on KeytrudaAfter trials halted, FDA issues warning on off-label use of the drug.
Two OTC Cold Medications Recalled Due to Bacterial Contamination Mid Valley Pharmaceutical recalls two drugs.
Should the FDA Drop High-Dose Opioids?
Should the FDA Drop High-Dose Opioids?A petition sent by multiple groups says yes.